HOME >> MEDICINE >> NEWS
Mayo Clinic study could lead to safer pesticides

ROCHESTER, Minn. -- Each year millions of dollars in crops are lost to two insects notorious for devastating farms: the greenbug (Schizaphis graminum) and the English grain aphid (Sitobion avenae). Although these tiny green insects are 1/16th of an inch long, they are heavyweights in the farm industry. In 2005, the Department of Agriculture reported that $100 million in crops were lost in six states to these pests.

In a new study in the October issue of Bioorganic & Medicinal Chemistry Letters, a Mayo Clinic researcher has published work that opens the door to the possibility of creating safer pesticides to control the greenbug and English grain aphid in crop farms. The key, according to the study's author, Yuan-Ping Pang, Ph.D., director of Mayo Clinic's Computer-Aided Molecular Design Laboratory, was in identifying an insect-specific enzyme that could be used as a direct target for a new insecticide that would not affect humans and animals. The research was done with the support of a powerful terascale supercomputer Dr. Pang designed to develop a three-dimensional model of an enzyme taken from the two insects. (Terascale refers to a computer so powerful it can perform one trillion operations per second.)

"We now have a blueprint that will enable the development of a new generation of pesticides that will not be toxic to humans. Ultimately, the idea would be that we would be able to eat apples without washing them -- even though it may be covered with pesticides," says Dr. Pang.

Greenbugs are found in North, Central and South America, Europe, Africa, the Middle East and Asia. Aphids have been present since 1912 in southern Europe, central Asia, the Middle East and Africa. Greenbugs are the most damaging of aphids because they suck plant juices and inject a toxin into the plant during the process, Dr. Pang says. The toxin causes more injury than the actual physical injury made by greenbugs.

To date a common method of protectin
'"/>

Contact: Amy Reyes
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
12-Oct-2006


Page: 1 2 3 4

Related medicine news :

1. Clinical data suggest potential versatility of ALIMTA-based regimens in lung cancer
2. Susan G. Komen for the Cure and American Society of Clinical Oncology partner in national initiative
3. Clinical review -- A psychological approach to the management of irritable bowel syndrome
4. NHLBI Asthma Clinical Research Networks and ALA ACRC Network to present at ATS 2007
5. New Mayo Clinic MRI technology enables noninvasive liver diagnoses
6. Clinical trial data for Perforomist Inhalation Solution presented at International ATS Conference
7. Elsevier launches the Clinics on ScienceDirect
8. Clinical guidelines for blood conservation during cardiac procedures developed
9. Clinical trial data for Perforomist Inhalation Solution to be presented at ATS on May 20, 2007
10. Mayo Clinic research in cardiovascular disease presented at Experimental Biology 2007
11. Mayo Clinic study finds heart transplant patients benefit from new approach to immunosuppression

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... 2017 (PRWEB) , ... July ... ... global provider of enterprise-grade IT operations analytics and application performance monitoring (APM) ... of world’s largest healthcare services providers. , According to Peter Ohrenberger, sales ...
(Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... For individuals ... utmost importance. The adjustable beds used in such facilities are specially designed to accommodate ... adequate arm support. , An inventor from Rochester, Ind., has invented the patent-pending ...
(Date:7/20/2017)... ... July 20, 2017 , ... Team Type 1 Foundation, a ... for everyone affected by diabetes, is teaming up with a Microsoft Corp. employee-led hackathon ... off on July 24th. , “Team Type 1’s mission overlaps seamlessly with Microsoft’s ...
(Date:7/20/2017)... ... July 20, 2017 , ... Vixiar Medical, Inc. , ... systems for monitoring cardiopulmonary diseases, announced today that it has raised seed round ... submissions and fund final engineering and initial production of the Company’s first product, ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... FDAnews Webinar**, Aug. 9, 2017 — 1:30 p.m. – 3:00 p.m. ET, ... inspections and boosting quality. , It’s known as the “CY2016 Annual FDA Medical ...
Breaking Medicine News(10 mins):
(Date:7/19/2017)... 2017  Mako Medical Laboratories partnered with Secretary Strickland, ... Assistance Fund (MFA) to bring 140 soldiers back home ... their families one last time before being deployed. Mako ... and logistics needed for these soldiers. "Mako Medical Laboratories ... families. We just wish we could bring them all ...
(Date:7/13/2017)... , July 13, 2017  Centurion Medical Products, a leader in ... DisImpactor ® fecal impaction removal device for hospice patient care. ... Centurion Medical ... Patient pain management and emotional comfort ... can help alleviate patient pain while preventing unneeded emergency department admission ...
(Date:7/11/2017)... , July 11, 2017 Zymo Research Corp., also known as ... can quantify biological aging in a precise manner using the myDNAge ™ ... Horvath , a professor of human genetics and biostatistics at the ... of Public Health , Zymo Research,s proprietary DNAge ™ technology is ... ...
Breaking Medicine Technology:
Cached News: